Biochemical and Pathological Response of Prostate Cancer in a Patient with Metastatic Renal Cell Carcinoma on Sunitinib Treatment

Sunitinib is a small molecular inhibitor of tyrosine kinases and is used to treat advanced renal cell carcinoma and gastrointestinal stromal tumour after disease progression or intolerance to imatinib therapy. Here, we describe biochemical and pathological response of prostate cancer in a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ik Chan, Lim, Jae Sung, Yun, Hwan Jung, Kim, Samyong, Kang, Dae Young, Lee, Hyo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299431/
https://www.ncbi.nlm.nih.gov/pubmed/19773269
http://dx.doi.org/10.1093/jjco/hyp110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299431/
https://www.ncbi.nlm.nih.gov/pubmed/19773269
http://dx.doi.org/10.1093/jjco/hyp110

Ejemplares similares